Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$27,699,745
-$922,956 QoQ
Shares Held
109,067
-6.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
#621
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hikari Tsushin, Inc. holds $60,254,195 across 7 Drug Manufacturers - General names. JNJ ranks #1 (46.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
109,067 | $27,699,745 | |
| 2 | ABBV |
AbbVie Inc.
|
101,443 | $25,527,116 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
81,141 | $4,675,344 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,812 | $1,132,342 | |
| 5 | NVO |
Novo Nordisk A S
|
23,512 | $1,127,165 | |
| 6 | AMGN |
Amgen Inc
|
233 | $84,373 | |
| 7 | OGN |
Organon & Co.
|
599 | $8,110 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,699,745 | 109,067 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $28,622,701 | 117,095 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $26,738,767 | 129,204 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $25,387,335 | 136,918 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $20,914,224 | 136,918 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $22,706,481 | 136,918 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,801,081 | 136,918 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $22,188,931 | 136,918 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $20,011,934 | 136,918 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $21,587,872 | 136,468 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $21,389,994 | 136,468 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $22,292,964 | 143,133 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $23,691,374 | 143,133 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $22,185,615 | 143,133 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,284,444 | 143,133 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $23,382,206 | 143,133 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $23,067,246 | 129,949 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $23,030,861 | 129,949 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $22,138,510 | 129,412 | Shares | Sole | 2022-02-08 | |
| 2021-06-30 | $19,844,580 | 120,460 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $18,449,931 | 112,260 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $17,667,478 | 112,260 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $16,713,268 | 112,260 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $15,787,123 | 112,260 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,720,653 | 112,260 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||